CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF CARDIOLOGY
Volume 37, Issue 4, Pages 531-546
Publisher
Elsevier BV
Online
2021-04-05
DOI
10.1016/j.cjca.2021.01.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
- (2020) Eileen O’Meara et al. CANADIAN JOURNAL OF CARDIOLOGY
- Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
- (2020) Paul W. Armstrong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin and Diuretic Use in Patients with Heart Failure and Reduced Ejection Fraction in DAPA-HF
- (2020) Alice M. Jackson et al. CIRCULATION
- Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial
- (2020) David D. Berg et al. JACC-Heart Failure
- NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction
- (2020) Domingo Pascual-Figal et al. JACC-Heart Failure
- Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF
- (2020) Pardeep S. Jhund et al. CIRCULATION
- Effect of Empagliflozin on the Clinical Stability of Patients with Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial
- (2020) Milton Packer et al. CIRCULATION
- Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
- (2020) Matteo Serenelli et al. EUROPEAN HEART JOURNAL
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
- (2020) John R. Teerlink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal Titration of Medical Therapy for Heart Failure with Reduced Ejection Fraction: CHAMP-HF Registry
- (2019) Stephen J. Greene et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study
- (2019) Rolf Wachter et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
- (2019) James L. Januzzi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
- (2019) Awais Malik et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
- (2019) Mikhail N. Kosiborod et al. CIRCULATION
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
- (2019) Felipe A. Martinez et al. CIRCULATION
- Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
- (2019) Nadia Bouabdallaoui et al. ESC Heart Failure
- Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction
- (2019) Kieran F. Docherty et al. EUROPEAN JOURNAL OF HEART FAILURE
- Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure
- (2019) Adam D. DeVore et al. JAMA Cardiology
- Medical Therapy for Heart Failure With Reduced Ejection Fraction
- (2018) Stephen J. Greene et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Wpływ terapii iwabradyną i beta-adrenolitykami na zaburzenia rytmu wywołane próbą dobutaminową
- (2017) Gurbet Özge Mert et al. Kardiologia Polska
- Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure
- (2016) Kumar Sanam et al. AMERICAN JOURNAL OF MEDICINE
- Ivabradine in Patients with ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: A Preliminary Randomized Prospective Study
- (2016) Francesco Barillà et al. CLINICAL DRUG INVESTIGATION
- Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study
- (2016) Francisco J. Hidalgo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Addition of Ivabradine to β-Blocker Improves Exercise Capacity in Systolic Heart Failure Patients in a Prospective, Open-Label Study
- (2015) A. E. Bagriy et al. ADVANCES IN THERAPY
- Contemporary Drug Development in Heart Failure
- (2015) Muthiah Vaduganathan et al. Circulation-Heart Failure
- Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
- (2015) Scott D. Solomon et al. EUROPEAN HEART JOURNAL
- The vulnerable phase after hospitalization for heart failure
- (2015) Stephen J. Greene et al. Nature Reviews Cardiology
- Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure
- (2015) Kurt W. Prins et al. JACC-Heart Failure
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
- (2013) Finlay A. McAlister ANNALS OF INTERNAL MEDICINE
- The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure
- (2012) Robert S. McKelvie et al. CANADIAN JOURNAL OF CARDIOLOGY
- Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
- (2012) Michael Böhm et al. Clinical Research in Cardiology
- Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: Data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial*
- (2011) Michael Böhm et al. CRITICAL CARE MEDICINE
- Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
- (2011) Jean-Claude Tardif et al. EUROPEAN HEART JOURNAL
- Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study
- (2011) John R Teerlink et al. LANCET
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
- (2010) Karl Swedberg et al. LANCET
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode
- (2009) G. Jondeau et al. EUROPEAN HEART JOURNAL
- Acute Heart Failure Syndromes
- (2009) Mihai Gheorghiade et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-Blockers
- (2008) Genevieve Flannery et al. AMERICAN JOURNAL OF CARDIOLOGY
- Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II
- (2008) M. Komajda et al. EUROPEAN HEART JOURNAL
- Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure
- (2008) Gregg C. Fonarow et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
- (2008) Kim Fox et al. LANCET
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started